Growth Metrics

Nektar Therapeutics (NKTR) Restructuring Costs (2022 - 2023)

Nektar Therapeutics (NKTR) has 2 years of Restructuring Costs data on record, last reported at $1.9 million in Q4 2023.

  • For Q4 2023, Restructuring Costs rose 131.11% year-over-year to $1.9 million; the TTM value through Sep 2024 reached $1.9 million, up 176.79%, while the annual FY2023 figure was $5.5 million, 82.67% down from the prior year.
  • Restructuring Costs reached $1.9 million in Q4 2023 per NKTR's latest filing, up from $652000.0 in the prior quarter.
  • Across five years, Restructuring Costs topped out at $27.8 million in Q2 2022 and bottomed at -$6.1 million in Q4 2022.